[High-flow nasal oxygen therapy and hypercapnic acute respiratory failure]

Abstract

Humidified high-flow nasal oxygen therapy (HFNO) has, in recent years, come to assume a key role in the management of hypoxemic acute respiratory failure (ARF). While non-invasive ventilation (NIV) currently represents the first-line ventilatory strategy in patients exhibiting hypercapnic ARF, the operating principles and physiological effects of HFNO could be interesting and useful in the initial management of hypercapnic ARF and/or after extubation, particularly in acute exacerbations of chronic obstructive pulmonary disease. Under these conditions, HFNO could be used either alone continuously or in combination with NIV during breaks in spontaneous breathing, depending on the severity and etiology of the underlying hypercapnic ARF.

Keywords: Acute respiratory failure; Broncho-pneumopathie chronique obstructive; Chronic obstructive pulmonary disease; Extubation; High-flow nasal oxygen therapy; Hypercapnia; Hypercapnie; Insuffisance respiratoire aiguë; Non-invasive ventilation; Oxygénothérapie humidifiée à haut débit; Ventilation non invasive.